Bleomycin-induced lung injury is enhanced by interferon-

Neville Berkman, Ronald H. Goldstein, Raphael Breuer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


We have evaluated the effect of intraperitoneal (IP) injection of human recombinant interferon-2α (IFN-α) on Bleomycin-induced pulmonary injury in hamsters. Pulmonary injury was induced by a single intratracheal (IT) instillation of Bleomycin (Bleo). Six groups of male Syrian hamsters were treated as follows: 1) IT Bleo and daily IP injections of low-dose interferon-α (2 x 104 U), 2) IT Bleo and daily IP injections of high-dose interferon-α (105 U), 3) IT Bleo and IP injections of saline, 4) IT saline and IP low-dose IFN-α, 5) IT saline and IP high-dose IFN-α(, 6) IT saline and IP saline. Animals were sacrificed 28 days after IT treatment. Lung injury was evaluated histologically and biochemically. Treatment of hamsters with low-dose but not high-dose IFN-α significantly augmented the Bleo-induced lung injury, as determined by a semiquantitative morphological index. Lung hydroxyproline measurements were highest in Bleo-low-dose-IFN-α followed by Bleo-high-dose-IFN-α and Bleo-Sal as compared to Sal-Sal and Sal-IFN-α controls. These results suggest that IFN-α augments Bleo-induced lung injury but that this effect is complex and does not follow a simple-dose-response pattern.

Original languageAmerican English
Pages (from-to)PL415-PL421
JournalLife Sciences
Issue number26
StatePublished - 23 May 1997


  • Bleomycin
  • Hamster
  • Interferon-α
  • Interstitial lung disease


Dive into the research topics of 'Bleomycin-induced lung injury is enhanced by interferon-'. Together they form a unique fingerprint.

Cite this